JAMIE PIACENTINI: Open Payments
NPI 1629518519 · SCARBOROUGH, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,754 in 83 payments from 16 companies in 2025. Trend: 2023 $1,030 · 2024 $774 · 2025 $1,754
Food & beverage: $1,673Education: $81
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $330 |
| Janssen Biotech, Inc. | 10 | $240 |
| Galderma Laboratories, L.P. | 10 | $164 |
| Regeneron Healthcare Solutions, Inc. | 3 | $151 |
| Organon LLC | 7 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $97 |
| GENZYME CORPORATION | 3 | $90 |
| UCB, Inc. | 3 | $84 |
| Incyte Corporation | 3 | $68 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, NEMLUVIO, Bimzelx, RINVOQ, OPZELURA, OTEZLA.
Industry payments across ME — which companies pay providers there.
